SHELDON KAPLAN to Neisseria meningitidis, Serogroup B
This is a "connection" page, showing publications SHELDON KAPLAN has written about Neisseria meningitidis, Serogroup B.
Connection Strength
1.306
-
Increased Risk of MenB Infection in College Students: Time to Reconsider Vaccine Recommendations? Pediatrics. 2019 01; 143(1).
Score: 0.627
-
Meningococcal Serogroup B Vaccine Immunogenicity in High-Risk Groups: What Are the Implications? Pediatrics. 2018 09; 142(3).
Score: 0.609
-
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine. J Infect Dis. 2007 May 15; 195(10):1472-9.
Score: 0.069